台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    32.75
  • 漲跌
    ▼0.75
  • 漲幅
    -2.24%
  • 成交量
    106
  • 產業
    上櫃 生技醫療類股
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生華科 (6492)籌碼相關-國票-北高雄 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

國票-北高雄 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/16033.80333.6032.75-3181-1.65%
2025/04/1400.00233.3532.75-2180-1.11%
2025/04/1000.00531.7531.75-5179-2.78%
2025/04/09328.5000.0028.9031771.69%
2025/04/07135.1000.0035.1011530.65%
2025/03/31138.1000.0038.1011610.62%
2025/03/2800.00139.5539.60-1157-0.63%
2025/03/27041.5000.0040.7501510.00%
2025/03/26041.9500.0041.5501490.00%
2025/02/26146.1000.0045.8011500.66%
2025/02/0500.000.143.0043.75-0.1193-0.05%
2025/01/22142.2000.0042.3012280.44%
2025/01/1600.000.142.1042.35-0.1378-0.03%
2025/01/1500.000.842.1642.15-0.8381-0.21%
2025/01/1400.000.542.5442.60-0.5382-0.13%
2025/01/1000.00144.0543.35-1387-0.26%
2025/01/09345.23145.0043.9523860.52%
2024/12/3000.00244.2043.00-2418-0.48%
2024/12/27544.81344.9344.2524210.47%
2024/12/26144.4000.0044.0514290.23%
2024/12/1800.00142.4042.30-1515-0.19%
2024/12/12143.1000.0042.9515910.17%
2024/12/1100.00143.0543.10-1592-0.17%
2024/12/09243.7800.0043.8026000.33%
2024/12/0500.000.545.0545.15-0.5616-0.08%
2024/12/04145.85145.8045.3506200.00%
2024/12/03145.2000.0045.2516290.16%
2024/12/02146.40145.1545.4006340.00%
2024/11/29145.4000.0046.0516390.16%
2024/11/18444.2300.0044.1046990.57%
2024/11/12247.3500.0047.3527260.28%
2024/11/11448.5000.0048.3547310.55%
2024/11/0700.00249.5349.45-2742-0.27%
2024/11/05149.6000.0049.6017550.13%
2024/11/0400.00149.7049.70-1774-0.13%
2024/11/0100.002449.8250.00-24778-3.08%
2024/10/30251.00151.5050.5017770.13%
2024/10/29252.65152.1052.1017720.13%
2024/10/281055.26854.7352.6027560.26%
2024/10/17051.7000.0050.5008500.00%
2024/10/11248.8500.0048.9521,0630.19%
2024/10/0100.00154.3054.20-11,047-0.10%
2024/09/27253.90154.4054.7011,0350.10%
2024/09/1900.00455.0053.20-4995-0.40%
2024/09/12247.1300.0047.3029790.20%
2024/09/03351.0000.0051.4031,0070.30%
2024/08/29450.6500.0050.0049930.40%
2024/08/2800.00350.3050.30-3981-0.31%
2024/08/2100.00250.5050.60-2948-0.21%
2024/08/2000.00450.9550.90-4943-0.42%
2024/08/15349.9000.0049.6039170.33%
2024/08/1300.00147.1047.10-1894-0.11%
2024/08/0800.00149.7549.75-1865-0.12%
2024/08/07451.20450.1050.7008560.00%
2024/08/06448.35249.0349.0028410.24%
2024/08/0200.00153.6053.00-1809-0.12%
2024/07/3100.00156.5056.50-1799-0.13%
2024/07/23256.6000.0054.1027700.26%
2024/07/22459.25359.2756.2017520.13%
2024/07/1900.00161.9058.10-1735-0.14%
2024/07/18861.951062.3262.20-2658-0.30%
2024/07/17355.6700.0058.9035430.55%
2024/07/1600.00257.0057.20-2427-0.47%
2024/07/09143.7000.0043.4013190.31%
2024/07/05445.1500.0045.6543121.28%
2024/06/27247.6500.0047.1022960.67%
2024/06/26148.7500.0048.7512880.35%
2024/06/25344.7000.0045.2032641.13%
2024/05/2700.00141.3041.35-1164-0.61%
2024/05/23142.40542.4742.10-4172-2.32%
2024/05/22342.85343.1743.2501740.00%
2024/05/20142.10242.0041.95-1174-0.57%
2024/05/02141.60141.4041.6501820.00%
2024/04/29141.35241.2041.30-1183-0.55%
2024/04/2200.00040.8040.6501870.00%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音